Molecular Vision Ltd. And AcronGenomics’ BioLED Platform One Step Closer To Completion

GENEVA--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM) and Molecular Vision, Ltd. -- an Imperial Innovations spin-out company -- today present a third R&D update of their joint collaboration, following the meeting that took place on the 27th of November 2006 at the headquarters of Acrongenomics' in Geneva.
MORE ON THIS TOPIC